State • Nevada

AB 259: Establishes provisions governing prescription drugs. (BDR 40-165)

Venicia ConsidineVetoed

AB 259 status: Vetoed — Vetoed by the Governor (updated Jun 12, 2025).

1

What this bill does

Overall score

Score50/100 civic fit
RiskHigh risk
ImpactModerate impact 60/100

Bill summary

Official

Lawmakers are currently working on a new bill (BDR 40-165) that would set new rules for how prescription drugs are handled. It is being debated in the state Assembly right now.

Key analysis

Constitutionality80%
Bipartisan50%
Public opinion50%
2

Impact analysis

Environment

Mixed / Neutral
50%

Benefits

  • no direct effect identified

Risks

  • no direct effect identified

Economy

Mixed / Neutral
50%

Benefits

  • potential to lower consumer drug costs

Risks

  • increased regulatory burden on pharmaceutical entities

Society

Mixed / Neutral
50%

Benefits

  • potential to increase patient drug accessibility

Risks

  • potential for industry resistance or supply chain impact
3

How trustworthy & consequential it is

Source

OpenStates

Confidence

low

low

Analysis status

OpenStates summary

Warning

LegiScan returned a PDF-only document. PDF extraction is not enabled in this build, so the pipeline used a safer fallback.

Limitation

Source information is limited to a brief summary.

4

Where it stands

Vetoed by the Governor.

Introduced

Complete

Committee

Complete

Floor

Complete

Governor

Complete
5

Enacted

Upcoming
5

How it affects your district

Set your location

Add your district to see how this bill may affect your community and who to contact.

6

Take action

Contact your representatives

Let them know how you feel about this bill.

Share your view

Join the discussion and see what others are saying.

Track this bill

Stay updated on progress and changes.